The Interaction Between Fungal Pathogens and Neural Cells
By Cesar Collado
Candida infections are a common cause of fungal infections in humans. Candida infections typically occur in areas such as the mouth, vagina, or skin. However, recent research has shed light on the interaction between Candida and the brain. Scientists have identified specific receptors in the brain that play a role in the recognition and response to Candida pathogens. Candida overgrowth in the body often results in many symptoms including central nervous systems or brain symptoms.
The discovery of Candida receptors in the brain has implications for understanding and treating neurological symptoms associated with Candida-related neurological infections.
There are currently more than 150 known species of Candida, and approximately 20 are known to cause infections in humans. Candida albicans is the main causative agent of candidiasis and the primary fungal infection in adults and pediatric patients. In the USA, it was reported that sepsis caused by C. albicans has a mortality rate of approximately 40%, which is higher than any other sepsis caused by bacteria or fungi. 
Candida is an Opportunistic Pathogen
Candida albicans is an opportunistic pathogen, which primarily affects neonates and immunocompromised individuals. The pathogen can invade the central nervous system, resulting in meningitis. 
1. Candida albicans are capable of crossing the Blood Brain Barrier (BBB). 
2. Studies have shown that Candida can invade the central nervous system and cause infections such as meningitis or brain abscesses. Researchers have discovered that certain receptors expressed by neural cells in the brain, such as microglia and astrocytes, play a crucial role in recognizing and responding to Candida pathogens. These receptors, known as pattern recognition receptors (PRRs), are responsible for detecting specific molecules or patterns associated with Candida, initiating an immune response.
3. Toll-like Receptors (TLRs) and Candida Recognition are now understood to be involved in Candida recognition. TLRs are present on the surface of immune cells, including those in the brain. They recognize specific components of Candida, such as fungal cell wall molecules, and trigger a signaling cascade that activates the immune response. TLRs in the brain are critical for initiating the defense mechanisms against Candida and maintaining the delicate balance between immune activation and preventing excessive inflammation.
4. Inflammatory Response and Candida-Induced Neurological Damage
Candida infections in the brain can lead to an inflammatory response, which involves the release of immune molecules and recruitment of immune cells to the site of infection. While inflammation is a crucial defense mechanism, excessive or prolonged inflammation can contribute to tissue damage and neurological complications. Understanding the interplay between Candida pathogens and the receptors in the brain can provide insights into the mechanisms of inflammation and guide therapeutic strategies to mitigate neurological damage.
Candida Receptors in the Brain: Implications for Therapeutic Strategies
The discovery of Candida receptors in the brain opens avenues for potential therapeutic interventions. By targeting these receptors or the signaling pathways associated with their activation, researchers may develop novel strategies to modulate the immune response, reduce inflammation, and enhance the clearance of Candida pathogens. This knowledge could contribute to the development of targeted therapies that specifically address Candida-related neurological infections, ultimately improving patient outcomes.
Future Directions and Challenges
While our understanding of Candida receptors in the brain has advanced in recent years, there is still much to learn. Further research is needed to unravel the complex interactions between Candida pathogens and the brain’s immune system. Additionally, identifying the precise mechanisms by which Candida evades immune recognition and establishes infection in the brain will be crucial for developing effective treatments. Collaboration between experts in microbiology, immunology, and neuroscience will be essential to further explore these areas.
The identification of Candida receptors in the brain represents a significant advancement in our understanding of the pathogenesis and immune response to Candida-related neurological infections. The interplay between Candida pathogens and neural cells through these receptors opens new avenues for therapeutic interventions.
Unique to Candida, the source of the candida is often the people in the home. This does not dismiss the need to eradicate and remove mold, fungi, yeasts and their remains. BioBalance provides multiple means including the use of HavenMist to quickly mist your home interior or Havenfog to saturate the home air volume and conducting a small particulate clean-up for maximum efficiency and effectiveness in removing fungi from your home.
While specific treatment for candida infections is limited. The tried-and-true strategies of starving the fungi, maintaining a balanced microbiome, and rinsing sinuses have all proven to be effective in managing candida overgrowth.
- Starve candida by maintaining an antifungal diet, avoiding sugar and refined carbohydrates.
- Add Agrumax Dietary Supplement to water to manage a balanced microbiome in the gut.
- Use Agrumax Dietary Supplement with a nasal rinse system.
- Macias-Paz, Ignacio Uriel. Et. al. “Candida albicans the main opportunistic pathogenic fungus in humans” Argentinian Microbiology Journal. August 3, 2022
- Jong AY. Et.al. “Traversal of Candida albicans across human blood-brain barrier in vitro.” Infectious Immunology. Jul, 2001
- Liu Y, et.al “Mechanisms of Candida albicans trafficking to the brain.” PLoS Pathog. 2011 Oct;7(10)
- Snarr BD, et. al. “It’s all in your head: antifungal immunity in the brain.” Current Opinions in Microbiology. Aug 2020.
- Inflammation Volume 13 – 2022 | https://doi.org/10.3389/fimmu.2022.1077335
- Wu, Chuyu . “The roles of fungus in CNS autoimmune and neurodegeneration disorders.” Frontiers in Immunology. 26 January 2023.
Cesar Collado is a former pharmaceutical R&D senior executive, venture capitalist, and seasoned strategy consultant in biotechnology and technology industries in general. He currently works as an advisor to multiple technology start-ups and advises several companies with technology solutions, including companies that provide healthcare and other services for environmental illness.
Cesar worked with MicroBalance Health Products from 2014-2019, where he had responsibility for strategy, revenues, marketing, and finance, as well as, writing all original content for the company’s newsletters during his tenure. Cesar is passionate about awareness and treatment of environmental illness as a significant, unmet and misdiagnosed, medical need. He has partnered with Integrative Physicians, Bau-Biologists, Environmental Inspectors, Mold Remediators, HVAC IAQ Specialists, and other professionals to generate educational materials for the environmentally ill. Cesar currently writes original content for ImmunoLytics, Bio-Balance, and CitriSafe: Protocols and Products for a Healthy Life.